The IPO Buzz: Kailera Therapeutics (KLRA) Upsizes IPO & Prices it at $16 – High End
Kailera Therapeutics (KLRA), a biotech targeting obesity, upsized its IPO at pricing to 39.06 million shares – up from 33.33 million in the prospectus – and priced the deal at $16.00 – the top of its $14.00-to-$16.00 range – to raise $624.96 million on Thursday night, April 16, 2026. Kailera Therapeutics’ stock is expected to […]
April 16, 2026 Read More